WN - copd

COPD patients' steps: Regular walking offers significant reduction in exacerbations

Pravda 2026-10-09, 23:28

Regular walking may help reduce the frequency of moderate and severe exacerbations in patients with chronic...

Lupin launches fixed dose triple combo inhaler for COPD in India

The Hindu 2026-10-07, 14:10

The product is an important addition to Lupin’s respiratory portfolio. ......

Could Laughter Help People With COPD Breathe Easier (MGC Diagnostics Corporation)

Public Technologies 2026-10-06, 18:01

) By MGC Diagnostics New research presented at ERS 2026 explores laughter therapy as a...

Lupin launches fixed-dose triple combination inhaler for COPD in India

Business Line 2026-10-06, 11:31

According to the company,...

Your Postal Code Shouldn’t Determine Your COPD Care. In Canada, It Still Does.

Nasdaq Globe Newswire 2026-10-05, 12:27

Lung Health Foundation’s new Canadian COPD Performance Index finds significant shortfalls in COPD care across...

COPD Flare-Up Symptoms: What to Watch for During Cold and Flu Season (Rotech Healthcare Holdings Inc)

Public Technologies 2026-10-02, 15:03

) October 1, 2026 When you live with COPD, some coughing or shortness of breath may be part of an ordinary...

Connect Biopharma Announces Positive Preliminary Topline Data from its Global Phase 2 Study of Rademikibart as an Add-on Treatment for Acute Exacerbations in Adults with COPD and Type 2 Inflammation (Form 8-K) (Connect Biopharma Holdings Ltd)

Public Technologies 2026-09-30, 12:58

) Connect Biopharma Announces Positive Preliminary Topline Data from its Global Phase 2 Study of Rademikibart...

Connect Biopharma Announces Positive Preliminary Topline Data from its Global Phase 2 Study of Rademikibart as an Add-on Treatment for Acute Exacerbations in Adults with COPD and Type 2 Inflammation (Connect Biopharma Holdings Ltd)

Public Technologies 2026-09-30, 12:58

) The text version of this document is not available. You can access the...

Kither Biotech Initiates Dosing of Patients in Phase 1b / 2a Study of KIT2014 in COPD

Nasdaq Globe Newswire 2026-09-29, 09:36

Kither Biotech announces that it has dosed the first patients in its Phase 1b / 2a clinical study of KIT2014...

Signs of COPD

Billings Gazette 2026-09-28, 13:42

Darcy, a former smoker, blamed her...

COPD Outreach service at Sligo University Hospital suspended since August as key post lies vacant

Irish Independent 2026-09-23, 14:47

There was a 78% reduction in admissions and an estimated €253,000 net savings over an 11 month study period...

VA Research Wrap Up: New findings on TBI, COPD and skin cancer (US Department of Veterans Affairs)

Public Technologies 2026-09-19, 22:39

) VA's Office of Research and Development recently published three News Briefs highlighting TBI resiliency, a...

Chronic Obstructive Pulmonary Disease (COPD) Market to reach USD 72.55 Billion by 2035 at 8.50% CAGR

The Daily Record - Dunn 2026-09-19, 18:11

COPD Market to Surge from USD 32.10 Billion in 2025 to USD 72.55 Billion by 2035-By Rising Disease Prevalence,...

First biologic treatment on the PBS for uncontrolled chronic obstructive pulmonary disease (COPD) (GlaxoSmithKline Australia Pty Ltd)

Public Technologies 2026-09-13, 12:00

) About NUCALA (mepolizumab)2 Indication NUCALA is indicated as an add-on maintenance treatment for adult...

Altesa BioSciences Presents Novel Clinical Data Demonstrating Vapendavir Significantly Reduces Key Inflammatory Biomarkers in Rhinovirus-Challenged COPD Patients at the European Respiratory Society International Congress 2026 (Forbion Capital Partners Management Services BV)

Public Technologies 2026-09-09, 12:00

) Results build on previously reported reductions in virus load, illness severity, improved quality of life...

Copd

Top News